A 24 week, MRI based, double-blind, randomised, placebo-controlled, modified dose-escalation trial to evaluate the safety, efficacy and pharmacokinetics of BIRT 2584 XX tablets at doses of 100, 300 and 500 mg administered once daily in patients with relapsing forms of Multiple Sclerosis. - ND A 24 week, MRI based, double-blind, randomised, placebo-controlled, modified dose-escalation trial t ...
A 24 week, MRI based, double-blind, randomised, placebo-controlled, modified dose-escalation trial to evaluate the safety, efficacy and pharmacokinetics of BIRT 2584 XX tablets at doses of 100, 300 and 500 mg administered once daily in patients with relapsing forms of Multiple Sclerosis. - ND A 24 week, MRI based, double-blind, randomised, placebo-controlled, modified dose-escalation trial t ...
relapsing forms of multiple sclerosis MedDRA version: 6.1;Level: PT;Classification code 10028245
Product Code: BIRT 2584XX Product Code: BIRT 2584 XX